Sri Lanka’s first portable clinical-quality ECG, Avidhrt Sense now at Dialog | Daily News

Sri Lanka’s first portable clinical-quality ECG, Avidhrt Sense now at Dialog

Chathura Peiris, Head - Product and Service Innovation, Dialog Axiata, Prabode Weebadde, Chairman, Avidhrt Inc., Dr. Sampath Withanawasam, Consultant Cardiologist - National Hospital of Colombo, Dr. Rainer Deutschmann, Group Chief Operating Officer - Dialog Axiata, Dr. Wasanthi Subasinghe, PhD (USA), Senior Lecturer - Faculty of Medicine, University of Kelaniya and Sameera Wijerathna, Director/CEO, My Health Solutions Private Limited

Chathura Peiris, Head - Product and Service Innovation, Dialog Axiata, Prabode Weebadde, Chairman, Avidhrt Inc., Dr. Sampath Withanawasam, Consultant Cardiologist - National Hospital of Colombo, Dr. Rainer Deutschmann, Group Chief Operating Officer - Dialog Axiata, Dr. Wasanthi Subasinghe, PhD (USA), Senior Lecturer - Faculty of Medicine, University of Kelaniya and Sameera Wijerathna, Director/CEO, My Health Solutions Private Limited

Dialog Axiata PLC, MyDoctor.lk and Avidhrt Inc. partner to launch Avidhrt Sense, the country’s first and only portable vital monitor, available to the Sri Lankan public. Avidhrt Sense is the only commercial product that offers a complete physiological monitoring solution for patients and health-conscious individuals.

Patients with suspected heart conditions, arrhythmia (primarily atrial fibrillation), or other heart-related illnesses, can use Avidhrt Sense to monitor cardiac rhythm, measure blood oxygen (SpO2) levels including hypoxia and measure body and ambient temperature. Health-conscious individuals can use Avidhrt Sense to monitor heart rate recovery and exercise capacity.

The device is primarily key for patients who have recently experienced heart surgery, cardiac stent placement, arrhythmia surgery or those that have recently suffered an embolic stroke, in order to continuously monitor and record their ECG. Additionally, understanding SpO2 levels, body and environmental temperature, can give further insight into other health conditions.

Dr. Robert Frank, CEO, Avidhrt said, “Avidhrt is pleased to partner with Dialog Axiata, PLC. Avidhrt is an innovative cardiac health company with offices in the US, Sri Lanka and India. The first commercial product of Avidhrt is an affordable, handheld cardiac monitor, powered by cloud-based machine learning technology. The innovative solutions created by Avidhrt are in synch with Dialog’s focus to use emerging technologies such as IoT (Internet of Things), Big Data, Cloud Computing and Artificial Intelligence to transform lives.”

Dr. Rainer Deutschmann, Group Chief Operating Officer, Dialog Axiata PLC said, “Dialog has been at the forefront to introduce next-generation technology and solutions to the Sri Lankan community, in line with its brand promise to deliver the future, today. In particular, Dialog continues to invest in Sri Lanka’s leading digital health and wellness platforms, such as Doc990, MyDoctor.lk and Yeheli.lk. Avidhrt is the latest addition to its suite of digital health services and we are pleased to make this affordable solution available at selected Dialog Customer Care Centres.”

Commenting, Sameera Wijerathna, Director/Chief Executive Officer, My Health Solutions Pvt Ltd said, “We are glad to partner with Dialog and Avidhrt as the exclusive medical service provider. We provide healthcare services to Sri Lankan consumers via digital mediums while ensuring and maintaining human interactions. Through this revolutionary device, we ensure that anyone using an Avidhrt monitor can not only monitor their heart conditions via ECG but also get expert advice at the click of a button from a qualified doctor.”

The Avidhrt Sense Device, system and method are patented technology in the United States of America.


 

Add new comment